The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days [version 1; peer review: 2 approved]

The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days [version 1; peer review: 2 approved]

Background: Never before have clinical trials drawn as much public attention as those testing interventions for COVID-19. We aimed to describe the worldwide COVID-19 clinical research response and its evolution over the first 100 days of the pandemic. Methods: Descriptive analysis of planned, ongoin...

Full description

Bibliographic Details
Main Authors: Perrine Janiaud, Cathrine Axfors, Janneke van't Hooft, Ramon Saccilotto, Arnav Agarwal, Christian Appenzeller-Herzog, Despina G. Contopoulos-Ioannidis, Valentin Danchev, Ulrich Dirnagl, Hannah Ewald, Gerald Gartlehner, Steven N. Goodman, Noah A. Haber, Angeliki Diotima Ioannidis, John P. A. Ioannidis, Mark P. Lythgoe, Wenyan Ma, Malcolm Macleod, Mario Malički, Joerg J. Meerpohl, Yan Min, David Moher, Blin Nagavci, Florian Naudet, Christiane Pauli-Magnus, Jack W. O'Sullivan, Nico Riedel, Jan A. Roth, Mandy Sauermann, Stefan Schandelmaier, Andreas M. Schmitt, Benjamin Speich, Paula R. Williamson, Lars G. Hemkens
Format: Article
Language:English
Published: F1000 Research Ltd 2020-10-01
Series:F1000Research
Online Access:https://f1000research.com/articles/9-1193/v1

Internet

https://f1000research.com/articles/9-1193/v1

Similar Items